UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma

The Journal of pathology, 2019-05, Vol.248 (1), p.51-65

2019

Volltextzugriff (PDF)

Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma

The Journal of pathology, 2022-12, Vol.258 (4), p.408-425

2022

Volltextzugriff (PDF)

Unraveling galectin-1 as a novel therapeutic target for cancer

Cancer treatment reviews, 2014-03, Vol.40 (2), p.307-319

2014

Volltextzugriff (PDF)

State of the art and future directions of pancreatic ductal adenocarcinoma therapy

Pharmacology & therapeutics (Oxford), 2015-11, Vol.155, p.80-104

2015

Volltextzugriff (PDF)

Stromal expression of SPARC in pancreatic adenocarcinoma

Cancer and metastasis reviews, 2013-12, Vol.32 (3-4), p.585-602

2013

Volltextzugriff (PDF)

Targeting cancer cell metabolism in pancreatic adenocarcinoma

Oncotarget, 2015-07, Vol.6 (19), p.16832-16847

2015

Volltextzugriff (PDF)

Targeting the TGFβ pathway for cancer therapy

Pharmacology & therapeutics (Oxford), 2015-03, Vol.147, p.22-31

2015

Volltextzugriff (PDF)

Pancreatic cancer orthotopic graft in a murine model

Acta Cirúrgica Brasileira, 2023-01, Vol.38, p.e382823

2023

Volltextzugriff (PDF)

MEK in cancer and cancer therapy

Pharmacology & therapeutics (Oxford), 2014-02, Vol.141 (2), p.160-171

2014

Volltextzugriff (PDF)

Netrin-4 Delays Colorectal Cancer Carcinomatosis by Inhibiting Tumor Angiogenesis

The American journal of pathology, 2011-04, Vol.178 (4), p.1861-1869

2011

Volltextzugriff (PDF)

High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis

Histopathology, 2015-11, Vol.67 (5), p.664-676

2015

Volltextzugriff (PDF)

Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib

Cancer chemotherapy and pharmacology, 2013-05, Vol.71 (5), p.1297-1307

2013

Volltextzugriff (PDF)

Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?

Cancers, 2021-06, Vol.13 (11), p.2708

2021

Volltextzugriff (PDF)

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas

Oncotarget, 2014-01, Vol.5 (1), p.78-94

2014

Volltextzugriff (PDF)

OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis

European journal of cancer (1990), 2014-09, Vol.50 (14), p.2463-2477

2014

Volltextzugriff (PDF)

Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy

Oral oncology, 2019-01, Vol.88, p.29-38

2019

Volltextzugriff (PDF)

Targeting the Ras–ERK pathway in pancreatic adenocarcinoma

Cancer and metastasis reviews, 2013-06, Vol.32 (1-2), p.147-162

2013

Volltextzugriff (PDF)

Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients

Oncotarget, 2015-08, Vol.6 (25), p.21614-21627

2015

Volltextzugriff (PDF)

Microbiome and pancreatic ductal adenocarcinoma

Clinics and research in hepatology and gastroenterology, 2021-03, Vol.45 (2), p.101589, Article 101589

2021

Volltextzugriff (PDF)

Ezurpimtrostat, A Palmitoyl-Protein Thioesterase-1 Inhibitor, Combined with PD-1 Inhibition Provides CD8+ Lymphocyte Repopulation in Hepatocellular Carcinoma

Targeted oncology, 2024-01, Vol.19 (1), p.95-106

2024

Volltextzugriff (PDF)

Bioisosteric modification of flavaglines

Tetrahedron letters, 2016-06, Vol.57 (26), p.2943-2944

2016

Volltextzugriff (PDF)

Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study

International journal of oncology, 2019-04, Vol.54 (4), p.1433-1445

2019

Volltextzugriff (PDF)

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma

Gastroenterology research and practice, 2010-01, Vol.2010 (2010), p.1-14

2010

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(108)

Sprache

Englisch
(108)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(22)
Oncology
(20)
Animals
(13)
Tumors
(12)
Pancreatic Cancer
(10)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Prognosis
(7)
Angiogenesis
(6)
Carcinoma, Pancreatic Ductal - Pathology
(6)
Cell Biology
(6)
Endocrinology & Metabolism
(6)
Female
(6)
Gastroenterology And Hepatology
(6)
Mice
(6)
Pancreatic Neoplasms - Pathology
(6)
Tumor Microenvironment
(6)
Adenocarcinoma
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma

Unraveling galectin-1 as a novel therapeutic target for cancer

State of the art and future directions of pancreatic ductal adenocarcinoma therapy

Stromal expression of SPARC in pancreatic adenocarcinoma

Targeting cancer cell metabolism in pancreatic adenocarcinoma

Targeting the TGFβ pathway for cancer therapy

Pancreatic cancer orthotopic graft in a murine model

MEK in cancer and cancer therapy

Netrin-4 Delays Colorectal Cancer Carcinomatosis by Inhibiting Tumor Angiogenesis

High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis

Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib

Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas

OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis

Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy

Targeting the Ras–ERK pathway in pancreatic adenocarcinoma

Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients

Microbiome and pancreatic ductal adenocarcinoma

Ezurpimtrostat, A Palmitoyl-Protein Thioesterase-1 Inhibitor, Combined with PD-1 Inhibition Provides CD8+ Lymphocyte Repopulation in Hepatocellular Carcinoma

Bioisosteric modification of flavaglines

Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma

Suchergebnisse filtern